These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Sulfasalazine therapy in inflammatory bowel disease.
    Author: Das KM.
    Journal: Gastroenterol Clin North Am; 1989 Mar; 18(1):1-20. PubMed ID: 2563989.
    Abstract:
    Sulfasalazine currently is the most commonly prescribed medication for inflammatory bowel disease. Insights into the pharmacokinetics, their side effects and mechanism and their possible mode of action has led to rational basis for its clinical use and the development of new related agents. This review summarizes these aspects and discusses the future role of sulfasalazine in the face of new oral preparations.
    [Abstract] [Full Text] [Related] [New Search]